Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 mars 2015 02h15 HE | Source: Neovacs, Inc.

Neovacs Scientific Advisory Board Endorses Company's Updated IFNa-Kinoid Development Plan

IFNα-Kinoid program to target Systemic Lupus Erythematosus (SLE) as first indication Important pipeline extension to dermatomyositis, an orphan condition linked to IFNα SAB...
20 janv. 2015 11h40 HE | Source: Neovacs, Inc.

Neovacs to Present at BIO CEO & Investor Conference

PARIS, Jan. 20, 2015 (GLOBE NEWSWIRE) -- NEOVACS (Alternext Paris:ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, announced today that the Company will be...
16 déc. 2014 02h00 HE | Source: Neovacs, Inc.

Neovacs Announces Top Line Phase IIb Clinical Trial Results of TNF-Kinoid in Rheumatoid Arthritis and Update on Clinical Programs

Phase IIb clinical trial of TNF-Kinoid in Rheumatoid Arthritis confirmed the good safety profile as well as antibody production, but failed to meet efficacy endpoints. Further evaluation is...